Round 1 (n = 30) | Round 2 (n = 15) | |
---|---|---|
Inclusion criteria | • Aged ≥12 years at time of consent • EITHER: ◦ Severe AA diagnosed by a clinician and determined by SALT ≥50% and never treated with JAKi, or ◦ Has received successful JAKi treatment, with SALT ≥50 prior to treatment | • Aged 18–60 years at time of consent • Severe AA diagnosed by a clinician and determined by SALT ≥50% • Current AA episode lasting > 6 months and no scalp hair regrowth over the past 6 months |
• A history of AA episodes lasting > 6 months but < 8 years • Sufficient physical, cognitive, reading and linguistic capacities to allow patients to actively participate in a 90 − minute interview • Fluent in English and can give documented informed consent | ||
Exclusion criteria | • Diagnosed with androgenic alopecia | • Diagnosed with other forms of alopecia including male or female pattern hair loss • Has experienced ≥95% scalp hair loss for ≥8 years |
• Diagnosed with active psoriasis, atopic dermatitis, or other dermatological condition that could be severe enough to impact this study, or any other serious condition that could interfere with this study • Known substance abusers |